P B Johansen - JoVE Visualize

Showing results (21-30 of 30) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 30 results.

Endocrine|April 17, 2002

Daily low-dose administration of growth hormone secretagogue stimulates pulsatile growth hormone secretion and elevates plasma insulin-like growth factor-1 levels in pigsK Malmlöf, M K Bauer, P B Johansen, et al.

Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|December 12, 2001

The growth hormone secretagogue ipamorelin counteracts glucocorticoid-induced decrease in bone formation of adult ratsN B Andersen, K Malmlöf, P B Johansen, et al.

Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|June 22, 1999

Ipamorelin, a new growth-hormone-releasing peptide, induces longitudinal bone growth in ratsP B Johansen, J Nowak, C Skjaerbaek, et al.

Pharmacology & Toxicology|June 1, 1994

Pharmacological characterization of a biosynthetic trisulfide-containing hydrophobic derivative of human growth hormone: comparison with standard 22 K growth hormoneM K Thomsen, B S Hansen, P Nilsson, et al.

APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|April 1, 1996

Effects of heparin and aminoguanidine on glomerular basement membrane thickening in diabetic ratsP S Oturai, R Rasch, E Hasselager, et al.

European Journal of Endocrinology|July 31, 1999

Pharmacological characterisation of a new oral GH secretagogue, NN703B S Hansen, K Raun, K K Nielsen, et al.

International Journal of Obesity (2005)|September 10, 2005

Influence of a selective histamine H3 receptor antagonist on hypothalamic neural activity, food intake and body weightK Malmlöf, F Zaragoza, V Golozoubova, et al.

Journal of Thrombosis and Haemostasis : JTH|March 28, 2018

Preclinical pharmacokinetics and biodistribution of subcutaneously administered glycoPEGylated recombinant factor VIII (N8-GP) and development of a human pharmacokinetic prediction modelF Rode, K Almholt, M Petersen, et al.

Journal of Thrombosis and Haemostasis : JTH|December 8, 2018

Factor VIII with a 237 amino acid B-domain has an extended half-life in F8-knockout miceE Bloem, D M Karpf, P L Nørby, et al.

Proceedings of the National Academy of Sciences of the United States of America|January 29, 2003

Lower blood glucose, hyperglucagonemia, and pancreatic alpha cell hyperplasia in glucagon receptor knockout miceR W Gelling, X Q Du, D S Dichmann, et al.

Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 30 results.

Endocrine|April 17, 2002

Daily low-dose administration of growth hormone secretagogue stimulates pulsatile growth hormone secretion and elevates plasma insulin-like growth factor-1 levels in pigsK Malmlöf, M K Bauer, P B Johansen, et al.

Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|December 12, 2001

The growth hormone secretagogue ipamorelin counteracts glucocorticoid-induced decrease in bone formation of adult ratsN B Andersen, K Malmlöf, P B Johansen, et al.

Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|June 22, 1999

Ipamorelin, a new growth-hormone-releasing peptide, induces longitudinal bone growth in ratsP B Johansen, J Nowak, C Skjaerbaek, et al.

Pharmacology & Toxicology|June 1, 1994

Pharmacological characterization of a biosynthetic trisulfide-containing hydrophobic derivative of human growth hormone: comparison with standard 22 K growth hormoneM K Thomsen, B S Hansen, P Nilsson, et al.

APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|April 1, 1996

Effects of heparin and aminoguanidine on glomerular basement membrane thickening in diabetic ratsP S Oturai, R Rasch, E Hasselager, et al.

European Journal of Endocrinology|July 31, 1999

Pharmacological characterisation of a new oral GH secretagogue, NN703B S Hansen, K Raun, K K Nielsen, et al.

International Journal of Obesity (2005)|September 10, 2005

Influence of a selective histamine H3 receptor antagonist on hypothalamic neural activity, food intake and body weightK Malmlöf, F Zaragoza, V Golozoubova, et al.

Journal of Thrombosis and Haemostasis : JTH|March 28, 2018

Preclinical pharmacokinetics and biodistribution of subcutaneously administered glycoPEGylated recombinant factor VIII (N8-GP) and development of a human pharmacokinetic prediction modelF Rode, K Almholt, M Petersen, et al.

Journal of Thrombosis and Haemostasis : JTH|December 8, 2018

Factor VIII with a 237 amino acid B-domain has an extended half-life in F8-knockout miceE Bloem, D M Karpf, P L Nørby, et al.

Proceedings of the National Academy of Sciences of the United States of America|January 29, 2003

Lower blood glucose, hyperglucagonemia, and pancreatic alpha cell hyperplasia in glucagon receptor knockout miceR W Gelling, X Q Du, D S Dichmann, et al.

Pageof 3